oxybutynin has been researched along with Hypertension, Pulmonary in 2 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary efficacy endpoint, mean difference between the two treatment arms in an 11-point numerical pain rating scale from baseline to 2 weeks after patch applications, was significantly lower on the capsaicin 8% patch treatment arm [P=0." | 9.19 | Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patients. ( Anand, P; Gibbs, JS; Gin-Sing, W; Huson, L; Iddamalgoda, T; Khengar, RH; Libri, V; Pinato, DJ, 2014) |
| "The primary efficacy endpoint, mean difference between the two treatment arms in an 11-point numerical pain rating scale from baseline to 2 weeks after patch applications, was significantly lower on the capsaicin 8% patch treatment arm [P=0." | 5.19 | Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patients. ( Anand, P; Gibbs, JS; Gin-Sing, W; Huson, L; Iddamalgoda, T; Khengar, RH; Libri, V; Pinato, DJ, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Light, A | 1 |
| Heininger, A | 1 |
| Wessman, K | 1 |
| Frutiger, K | 1 |
| White, RJ | 1 |
| Libri, V | 1 |
| Gibbs, JS | 1 |
| Pinato, DJ | 1 |
| Iddamalgoda, T | 1 |
| Khengar, RH | 1 |
| Gin-Sing, W | 1 |
| Huson, L | 1 |
| Anand, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-blind, Randomized, Crossover Clinical Study to Assess the Efficacy of Qutenza® for the Reduction of Site Pain Caused by Continuous Subcutaneous Infusion of Remodulin®, in Pulmonary Arterial Hypertension Patients[NCT01393795] | Phase 2 | 11 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for oxybutynin and Hypertension, Pulmonary
| Article | Year |
|---|---|
Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patients.
Topics: Adult; Aged; Antihypertensive Agents; Capsaicin; Double-Blind Method; Epoprostenol; Female; Humans; | 2014 |
1 other study available for oxybutynin and Hypertension, Pulmonary
| Article | Year |
|---|---|
8% Capsaicin Patch as Analgesia for Severe Treprostinil Infusion Site Pain.
Topics: Aged; Antihypertensive Agents; Capsaicin; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Inf | 2017 |